STAAR Surgical Co Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
STAAR Surgical Co (STAA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$845.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2022-02-23
- STAAR Surgical Co valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2021-01-01 was -$4.10M.
- STAAR Surgical Co valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2020-10-02 was -$154.00K.
- STAAR Surgical Co valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2020-07-03 was $0.00.
- STAAR Surgical Co valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2020-04-03 was $4.75M.
- STAAR Surgical Co valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was -$845.00K, a 270.71% decline from fiscal 2021.
- STAAR Surgical Co valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $495.00K, a 85.34% decline from fiscal 2020.
- STAAR Surgical Co valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $3.38M.
- STAAR Surgical Co valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2014 was $1.01M, a 132.79% increase from fiscal 2012.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 6 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 9 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | -$845.00K 10-K · filed 2022-02-23 | ||||
| 2021-01-01 | -$4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$4.25M derived: sum of 2 quarters · filed 2022-02-23 | -$4.25M derived: sum of 3 quarters · filed 2022-02-23 | $495.00K 10-K · filed 2022-02-23 | |
| 2020-10-02 | -$154.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$154.00K derived: sum of 2 quarters · filed 2020-11-04 | $4.59M 10-Q · filed 2020-11-04 | ||
| 2020-07-03 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $4.75M 10-Q · filed 2020-08-05 | |||
| 2020-04-03 | $4.75M 10-Q · filed 2020-05-06 | ||||
| 2020-01-03 | $3.38M 10-K · filed 2022-02-23 | ||||
| 2014-01-03 | $575.00K derived: 10-K 12 month − 10-K 9 month · filed 2015-03-13 | $1.01M derived: sum of 2 quarters · filed 2015-03-13 | $1.01M 10-K · filed 2015-03-13 | -$1.01M 10-K · filed 2014-03-12 | |
| 2013-09-27 | $433.00K 10-K · filed 2014-03-12 | $433.00K 10-K · filed 2014-03-12 | |||
| 2012-12-28 | $433.00K 10-K · filed 2015-03-13 | $16.00K 10-K · filed 2013-03-12 | |||
| 2011-12-30 | $312.00K 10-K · filed 2014-03-12 | ||||
| 2010-12-31 | $137.00K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |